POC Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global POC Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027. Segment by Type Blood Glucose Testing Infectious Diseases Testing Cardiac Markers Testing Coagulation Testing Pregnancy and Fertility Testing Blood Gas/Electrolytes Testing Tumor Markers Testing Urinalysis Testing Cholesterol Testing Segment by Application Clinics Hospitals Laboratory Others By Company Abbott Roche Abbott Laboratories Johnson & Johnson Siemens Healthcare Danaher Bayer Healthcare Beckman Coulter Nipro Diagnostics Bio-Rad Laboratories Nova Biomedical BioMerieux Quidel Helena Laboratories OraSure Technologies Accriva Abaxis Chembio Diagnostics Trinity Biotech By Region North America U.S. Canada Europe Germany France U.K. Italy Russia Asia-Pacific China Japan South Korea India Australia Taiwan Indonesia Thailand Malaysia Philippines Vietnam Latin America Mexico Brazil Argentina Middle East & Africa Turkey Saudi Arabia
1 Study Coverage 1.1 POC Diagnostics Product Introduction 1.2 Market by Type 1.2.1 Global POC Diagnostics Market Size Growth Rate by Type 1.4.2 Blood Glucose Testing 1.4.3 Infectious Diseases Testing 1.2.4 Cardiac Markers Testing 1.2.5 Coagulation Testing 1.2.6 Pregnancy and Fertility Testing 1.2.7 Blood Gas/Electrolytes Test
